- Intellectual Property
- False Advertising, Lanham Act and Unfair Competition
- IP Licensing, Technology and Commercial Transactions
- Life Sciences and FDA
- Trademark Applications and Prosecution
- Trademarks and Trade Dress
- Food and Beverage
|University ||Brown University, A.B.|
|Law School||The National Law Center, George Washington University, J.D., with honors|
|Admitted||1976, District of Columbia; U.S. Supreme Court; U.S. Court of Appeals for the Federal Circuit; U.S. Court of International Trade|
•Member, American Bar Association
•Member, Federal Circuit Bar Association
•Member, International Trademark Association
•Member, Food and Drug Law Institute
•Member, NGLBT Association
Mr. Reichertz is a partner in the Washington D.C. office, and is leader of the firm's Food and Drug Law Group. He also serves as co-leader of the firm's Life Sciences group.
Areas of Practice
Mr. Reichertz concentrates in both food and drug regulatory law and intellectual property law. He counsels companies whose products are regulated by the FDA under the Federal Food Drug and Cosmetic Act. He represents manufacturers and distributors in obtaining approval to market drugs, medical devices, food, dietary supplements and cosmetic products, and counsels on all aspects of marketing of such products, including providing advice on labeling, advertising, manufacturing and distribution issues. He negotiates and prepares clinical trial, distribution, supply, contract manufacturing and quality agreements. He also counsels on related federal and state regulatory statutes.
Mr. Reichertz's practice also includes advising advertising agencies, clinical investigators, research organizations and other non-manufacturers on compliance with the Federal Food Drug and Cosmetic Act. He represents clients in FDA rulemaking proceedings, and in enforcement proceedings brought by the U.S. on behalf of the FDA. Mr. Reichertz also represents clients in advertising disputes related to FDA-regulated products, both at the FDA and in false advertising litigation under Section 43(a) of the Lanham Act and before the National Advertising Division of the Better Business Bureau.
In addition, Mr. Reichertz practices in intellectual property, specifically in trademarks, copyrights, trade secrets and licensing. His trademark expertise includes counseling and advising clients on the selection and adoption of trademarks, as well as the prosecution of trademark applications in the United States Patent and Trademark Office. He also prepares and negotiates trademark licensing agreements.
•Recommended, Healthcare: Life Sciences, The Legal 500 United States, 2013 and 2014
•Martindale-Hubbell Intellectual Property Washington, D.C. Top Rated Lawyer, 2012
•Washington SmartCEO, Legal Elite, Readers Pick Top Local Attorneys, December 2009 and December 2010
•Which Lawyer?, Life Sciences/Regulatory law, Nationally ranked by Practical Law Company, 2007
Documents by this lawyer on Martindale.com
A Short-Lived Victory for Generic Manufacturers? - Part 2
Peter S. Reichertz, January 6, 2014
In our prior blog post of the same title on July 5, 2013, we predicted that the protection from product liability/failure to warn litigation for generic manufacturers as a result of the Supreme Court decision in Mutual Pharmaceutical Co., Inc. v. Bartlett, 133 S. Ct. 2466 (2013) might be...
View Ratings & Reviews
|Profile Visibility |
|#3,974 in weekly profile views out of 51,510 lawyers in Washington, District of Columbia|
|#133,404 in weekly profile views out of 1,587,858 total lawyers Overall|